Concepedia

Vatche Tchekmedyian

VT

9

Publications

1.2K

Citations

9

H-Index

2017

Active since

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Brigham and Women's Hospital

Dana-Farber Cancer Institute

Massachusetts General Hospital

Tufts Medical Center

Vatche Tchekmedyian is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, oncology, and cancer therapeutics.

ORCID

Top concepts

Publications per year

2017–2024

9

Publications

9

Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for Lymphoma

Christopher J. Gibson, R. Coleman Lindsley, Vatche Tchekmedyian et al. · Journal of Clinical Oncology · 2017 · 455 citations · Full text

Vemurafenib Redifferentiation of <i>BRAF</i> Mutant, RAI-Refractory Thyroid Cancers

Lara Dunn, Eric J. Sherman, Shrujal S. Baxi et al. · The Journal of Clinical Endocrinology & Metabolism · 2018 · 231 citations · Full text

Phase II Study of Lenvatinib in Patients With Progressive, Recurrent or Metastatic Adenoid Cystic Carcinoma

Vatche Tchekmedyian, Eric J. Sherman, Lara Dunn et al. · Journal of Clinical Oncology · 2019 · 228 citations · Full text

SWI/SNF Complex Mutations Promote Thyroid Tumor Progression and Insensitivity to Redifferentiation Therapies

Mahesh Saqcena, Luis J. Leandro‐García, Jesper L.V. Mååg et al. · Cancer Discovery · 2020 · 106 citations · Full text

Cemiplimab for Kidney Transplant Recipients With Advanced Cutaneous Squamous Cell Carcinoma

Glenn J. Hanna, Harita Dharanesswaran, Anita Giobbie‐Hurder et al. · Journal of Clinical Oncology · 2024 · 56 citations · Full text

Rows per page

1–5 of 9